<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Consilium Medicum</journal-id><journal-title-group><journal-title xml:lang="en">Consilium Medicum</journal-title><trans-title-group xml:lang="ru"><trans-title>Consilium Medicum</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>Consilium Medicum</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2075-1753</issn><issn publication-format="electronic">2542-2170</issn><publisher><publisher-name xml:lang="en">Consilium Medicum</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">704083</article-id><article-id pub-id-type="doi">10.26442/20751753.2026.2.203620</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">The use of magnetic resonance imaging as a first-choice diagnostic method in emergency vascular neurology</article-title><trans-title-group xml:lang="ru"><trans-title>Использование магнитно-резонансной томографии в качестве метода первого выбора диагностики в ургентной ангионеврологии</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4174-7114</contrib-id><name-alternatives><name xml:lang="en"><surname>Tairova</surname><given-names>Raisa T.</given-names></name><name xml:lang="ru"><surname>Таирова</surname><given-names>Раиса Таировна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Chief Phys.</p></bio><bio xml:lang="ru"><p>глав. врач ФГБУ ФЦМН, проф. каф. неврологии, нейрохирургии и медицинской генетики Научно-исследовательского института ФГАОУ ВО «РНИМУ им. Н.И. Пирогова» (Пироговский Университет)</p></bio><email>marskayana@gmail.com</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0003-4472-6604</contrib-id><name-alternatives><name xml:lang="en"><surname>Glotova</surname><given-names>Nataliya A.</given-names></name><name xml:lang="ru"><surname>Глотова</surname><given-names>Наталия Александровна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>канд. мед. наук, зав. неврологическим отд-нием для больных с острыми нарушениями мозгового кровообращения</p></bio><email>marskayana@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5294-5706</contrib-id><name-alternatives><name xml:lang="en"><surname>Soldatov</surname><given-names>Mikhail A.</given-names></name><name xml:lang="ru"><surname>Солдатов</surname><given-names>Михаил Анатольевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Res., Neurol.</p></bio><bio xml:lang="ru"><p>науч. сотр., врач-невролог</p></bio><email>marskayana@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1726-6801</contrib-id><name-alternatives><name xml:lang="en"><surname>Gubskiy</surname><given-names>Ilya L.</given-names></name><name xml:lang="ru"><surname>Губский</surname><given-names>Илья Леонидович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>канд. мед. наук, науч. сотр.</p></bio><email>marskayana@gmail.com</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0789-4823</contrib-id><name-alternatives><name xml:lang="en"><surname>Marskaya</surname><given-names>Nataliya A.</given-names></name><name xml:lang="ru"><surname>Марская</surname><given-names>Наталия Андреевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Res.</p></bio><bio xml:lang="ru"><p>науч. сотр. отд. сосудистых заболеваний нервной системы</p></bio><email>marskayana@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5617-4497</contrib-id><name-alternatives><name xml:lang="en"><surname>Khasanova</surname><given-names>Liana T.</given-names></name><name xml:lang="ru"><surname>Хасанова</surname><given-names>Лиана Темборовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>канд. мед. наук, врач-невролог, врач – анестезиолог-реаниматолог</p></bio><email>marskayana@gmail.com</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4913-351X</contrib-id><name-alternatives><name xml:lang="en"><surname>Kiseleva</surname><given-names>Tatiana V.</given-names></name><name xml:lang="ru"><surname>Киселева</surname><given-names>Татьяна Владимировна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Res.</p></bio><bio xml:lang="ru"><p>науч. сотр. отд. сосудистых заболеваний нервной системы</p></bio><email>marskayana@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7423-1229</contrib-id><name-alternatives><name xml:lang="en"><surname>Gubsky</surname><given-names>Leonid V.</given-names></name><name xml:lang="ru"><surname>Губский</surname><given-names>Леонид Васильевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>D. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>д-р мед. наук, гл. науч. сотр. лаб. нейрорегенерации</p></bio><email>marskayana@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6250-0762</contrib-id><name-alternatives><name xml:lang="en"><surname>Shamalov</surname><given-names>Nikolay A.</given-names></name><name xml:lang="ru"><surname>Шамалов</surname><given-names>Николай Анатольевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>D. Sci. (Med.), Federal Center of Brain Research and Neurotechnologies</p></bio><bio xml:lang="ru"><p>д-р мед. наук, дир. Института цереброваскулярной патологии и инсульта</p></bio><email>marskayana@gmail.com</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Federal Center of Brain Research and Neurotechnologies</institution></aff><aff><institution xml:lang="ru">ФГБУ «Федеральный центр мозга и нейротехнологий» ФМБА России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Pirogov Russian National Research Medical University (Pirogov University)</institution></aff><aff><institution xml:lang="ru">ФГАОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России (Пироговский Университет)</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Municipal Clinical Hospital №31 named after Academician G.M. Savelyeva</institution></aff><aff><institution xml:lang="ru">ГБУЗ «Городская клиническая больница №31 им. акад. Г.М. Савельевой Департамента здравоохранения г. Москвы»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2026-04-10" publication-format="electronic"><day>10</day><month>04</month><year>2026</year></pub-date><volume>28</volume><issue>2</issue><issue-title xml:lang="en">Neurology and rheumatology</issue-title><issue-title xml:lang="ru">Неврология и ревматология</issue-title><fpage>81</fpage><lpage>88</lpage><history><date date-type="received" iso-8601-date="2026-03-11"><day>11</day><month>03</month><year>2026</year></date><date date-type="accepted" iso-8601-date="2026-03-16"><day>16</day><month>03</month><year>2026</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2026, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2026, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://consilium.orscience.ru/2075-1753/article/view/704083">https://consilium.orscience.ru/2075-1753/article/view/704083</self-uri><abstract xml:lang="en"><p><bold>Background.</bold> Reducing time from the onset of first symptoms of acute cerebrovascular accident to patient admission to a stroke center and performing neuroimaging (CT or MRI) for diagnosis verification not only aids in diagnosing emergency conditions in emergency vascular neurology but also helps shorten the time to treatment initiation, thereby contributing to improved clinical outcomes.</p> <p><bold>Aim.</bold> To assess the use of MRI as the first-choice diagnostic method in adults transported by emergency medical services (EMS) with suspected acute cerebrovascular accident.</p> <p><bold>Materials and methods.</bold> This single-center observational study included adults (≥18 years) transported to the Federal Center of Brain Research and Neurotechnologies from January 1 to December 31, 2025 with suspected acute cerebrovascular accident were included. MRI was used as the initial imaging modality in the absence of contraindications; CT was performed when MRI was contraindicated. Time metrics, imaging utilization, reperfusion therapy and in-hospital mortality were analyzed.</p> <p><bold>Results.</bold> During the observation period, 712 patients with suspected acute stroke were transported by EMS; acute cerebrovascular accident was confirmed in 482 (67.7%) patients, while in 230 (32.3%) cases another diagnosis was made: 80 (11.2%) patients were found to have other neurological pathologies that required hospitalization, 15 (2.1%) cases were diagnosed with somatic pathologies, and these patients were also hospitalized, while 135 (19%) cases did not require hospitalization. MRI was performed in 611 cases (85.8%) and CT in 101 (14.2%). Median door-to-imaging time was 17 min. Reperfusion therapy for ischemic stroke was delivered in 59 patients. Overall in-hospital mortality among admitted patients was 3.1%, and mortality in acute cerebrovascular accidents was 4.1%.</p> <p><bold>Conclusion.</bold> The use of MRI as a first-choice diagnostic method in patients with suspected acute stroke in a 24/7 hospital allows for rapid neuroimaging, providing a more accurate diagnosis and reducing unnecessary hospital admissions of patients with alternative diagnoses – «stroke mimics».</p></abstract><trans-abstract xml:lang="ru"><p><bold>Обоснование.</bold> Уменьшение интервала времени с момента появления первых симптомов острого нарушения мозгового кровообращения (ОНМК) до поступления пациента в специализированный стационар и проведения нейровизуализационного (компьютерной томографии – КТ, или магнитно-резонансной томографии – МРТ) исследования головного мозга для верификации диагноза не только позволяет решить вопрос с диагностикой неотложных состояний в ангионеврологии, но и способствует сокращению времени до начала терапии, соответственно, приводит к лучшему клиническому исходу заболевания.</p> <p><bold>Цель.</bold> Изучить особенности применения МРТ в качестве первого метода нейровизуализации у пациентов, доставленных бригадами скорой медицинской помощи (СМП) с подозрением на ОНМК.</p> <p><bold>Материалы и методы.</bold> В одноцентровое наблюдательное исследование включены пациенты старше 18 лет, доставленные в ФГБУ ФЦМН с 1 января по 31 декабря 2025 г. с подозрением на ОНМК: при отсутствии противопоказаний в качестве метода первого выбора использовали МРТ, при наличии противопоказаний выполняли КТ. Анализировали структуру диагнозов у пациентов, доставленных бригадами СМП, после обследования, временные показатели, частоту выполнения реперфузионной терапии, больничную летальность.</p> <p><bold>Результаты.</bold> За период наблюдения с подозрением на ОНМК бригадами СМП доставлены 712 пациентов, диагноз ОНМК подтвержден у 482 (67,7%), в 230 (32,3%) случаях поставлен другой диагноз: у 80 (11,2%) человек выявлена другая неврологическая патология, которая потребовала госпитализации, у 15 (2,1%) диагностирована соматическая патология, которые также были госпитализированы, 135 (19%) пациентов в госпитализации не нуждались. МРТ выполнена в 611 (85,8%) случаях, КТ – в 101 (14,2%). Медиана времени от поступления до начала нейровизуализации составила 17 мин. Реперфузионная терапия при ишемическом инсульте проведена у 59 человек. Общая больничная летальность среди госпитализированных составила 3,1%, летальность при ОНМК – 4,1%.</p> <p><bold>Заключение.</bold> Применение МРТ в качестве метода первого выбора диагностики у пациентов с подозрением на ОНМК в условиях круглосуточного стационара позволяет проводить нейровизуализацию в короткие сроки, обеспечивая уточнение диагноза и снижение необоснованных госпитализаций пациентов с альтернативными диагнозами – «масками инсульта».</p></trans-abstract><kwd-group xml:lang="en"><kwd>stroke</kwd><kwd>acute cerebrovascular accident</kwd><kwd>magnetic resonance imaging</kwd><kwd>X-ray computed tomography</kwd><kwd>neuroimaging</kwd><kwd>«stroke mimics»</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>инсульт</kwd><kwd>острое нарушение мозгового кровообращения</kwd><kwd>магнитно-резонансная томография</kwd><kwd>компьютерная томография</kwd><kwd>нейровизуализация</kwd><kwd>«маски инсульта»</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution xml:lang="ru">Федеральное медико-биологическое агентство</institution></institution-wrap><institution-wrap><institution xml:lang="en">Federal Medical and Biological Agency</institution></institution-wrap></funding-source><award-id>388-00081-25-00</award-id></award-group><funding-statement xml:lang="en">The study was conducted as part of the State Assignment of the Federal Center of Brain Research and Neurotechnologies, "Treatment Effect 2025–2027", Registration Card No. 125052706451-2.</funding-statement><funding-statement xml:lang="ru">Исследование выполнено в рамках государственного задания ФГБУ ФЦМН «Эффект лечения 2025–2027», регистрационная карта №125052706451-2.</funding-statement></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>GBD 2021 Stroke Risk Factor Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol. 2024;23(10):973-1003. DOI:10.1016/S1474-4422(24)00369-7</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Игнатьева В.И., Вознюк И.А., Шамалов Н.А., и др. Социально-экономическое бремя инсульта в Российской Федерации. Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски. 2023;123(8-2):5-15 [Ignatyeva VI, Voznyuk IA, Shamalov NA, et al. Social and economic burden of stroke in Russian Federation. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(8-2):5-15 (in Russian)]. DOI:10.17116/jnevro20231230825</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Скворцова В.И., Голухов Г.Н., Губский Л.В., и др. Системная тромболитическая терапия при ишемическом инсульте. Журнал неврологии и психиатрии им. С.С. Корсакова. 2006;106(12): 24-31 [Skvortsova VI, Golukhov GN, Gubskii LV, et al. Sistemnaia tromboliticheskaia terapiia pri ishemicheskom insul'te. S.S. Korsakov Journal of Neurology and Psychiatry. 2006;106(12):24-31 (in Russian)].</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Скворцова В.И., Шетова И.М., Какорина Е.П., и др. Результаты реализации «Комплекса мероприятий по совершенствованию медицинской помощи пациентам с острыми нарушениями мозгового кровообращения». Журнал неврологии и психиатрии им. С.С. Корсакова. 2018;118(4):5-12 [Skvortsova VI, Shetova IM, Kakorina EP, et al. Results of implementation of a «Complex of measures to improve medical care for patients with stroke in the Russian Federation». S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(4):5-12 (in Russian)]. DOI:10.17116/jnevro2018118415-12</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Kidwell CS, Hsia AW. Imaging of the brain and cerebral vasculature in patients with suspected stroke: advantages and disadvantages of CT and MRI. Curr Neurol Neurosci Rep. 2006;6(1):9-16. DOI:10.1007/s11910-996-0003-1</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Chalela JA, Kidwell CS, Nentwich LM, et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet. 2007;369(9558):293-8. DOI:10.1016/S0140-6736(07)60151-2</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Fiebach JB, Schellinger PD, Jansen O, et al. CT and diffusion-weighted MR imaging in randomized order: diffusion-weighted imaging results in higher accuracy and lower interrater variability in the diagnosis of hyperacute ischemic stroke. Stroke. 2002;33(9):2206-10. DOI:10.1161/01.str.0000026864.20339.cb</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Mullins ME, Schaefer PW, Sorensen AG, et al. CT and conventional and diffusion-weighted MR imaging in acute stroke: study in 691 patients at presentation to the emergency department. Radiology. 2002;224(2):353-60. DOI:10.1148/radiol.2242010873</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Schellinger PD, Bryan RN, Caplan LR, et al. Evidence-based guideline: The role of diffusion and perfusion MRI for the diagnosis of acute ischemic stroke [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2010;75(2):177-85 (in English). DOI:10.1212/WNL.0b013e3181e7c9dd</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Cabral Frade H, Wilson SE, Beckwith A, Powers WJ. Comparison of Outcomes of Ischemic Stroke Initially Imaged With Cranial Computed Tomography Alone vs Computed Tomography Plus Magnetic Resonance Imaging. JAMA Netw Open. 2022;5(7):e2219416. DOI:10.1001/jamanetworkopen.2022.19416</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Fischer U, Branca M, Bonati LH, et al. Magnetic Resonance Imaging or Computed Tomography for Suspected Acute Stroke: Association of Admission Image Modality with Acute Recanalization Therapies, Workflow Metrics, and Outcomes. Ann Neurol. 2022;92(2):184-94. DOI:10.1002/ana.26413</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Edlow BL, Hurwitz S, Edlow JA. Diagnosis of DWI-negative acute ischemic stroke: A meta-analysis. Neurology. 2017;89(3):256-62. DOI:10.1212/WNL.0000000000004120</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Wycliffe ND, Choe J, Holshouser B, et al. Reliability in detection of hemorrhage in acute stroke by a new three-dimensional gradient recalled echo susceptibility-weighted imaging technique compared to computed tomography: a retrospective study. J Magn Reson Imaging. 2004;20(3): 372-7. DOI:10.1002/jmri.20130</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Brazzelli M, Sandercock PA, Chappell FM, et al. Magnetic resonance imaging versus computed tomography for detection of acute vascular lesions in patients presenting with stroke symptoms. Cochrane Database Syst Rev. 2009;(4):CD007424. DOI:10.1002/14651858.CD007424.pub2</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Romanova AL, Nemeth AJ, Berman MD, et al. Magnetic resonance imaging versus computed tomography for identification and quantification of intraventricular hemorrhage. J Stroke Cerebrovasc Dis. 2014;23(8):2036-40. DOI:10.1016/j.jstrokecerebrovasdis.2014.03.005</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Mitchell P, Wilkinson ID, Hoggard N, et al. Detection of subarachnoid haemorrhage with magnetic resonance imaging. J Neurol Neurosurg Psychiatry. 2001;70(2):205-11. DOI:10.1136/jnnp.70.2.205</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Плотников Д.М., Иванникова О.А., Алифирова В.М., и др. Итоги реализации мероприятий, направленных на совершенствование оказания медицинской помощи больным с сосудистыми заболеваниями на территории томской области в 2012 г. Бюллетень сибирской медицины. 2020;12(5):87-98 [Plotnikov DM, Ivannikova OA, Alifirova AM, et al. Activities results aimed at improved medical assistance to the vascular patients in Tomsk Region. Bulletin of Siberian Medicine. 2020;12(5):87-98 (in Russian)]. DOI:10.20538/1682-0363-2013-5-87-98</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Farid HA, Naqvi A. The Burden of Stroke Mimics Among Hyperacute Stroke Unit Attendees with Special Emphasis on Migraine: A 10-Year Evaluation. Cureus. 2024;16(5):e59700. DOI:10.7759/cureus.59700</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Hand PJ, Kwan J, Lindley RI, et al. Distinguishing between stroke and mimic at the bedside: the brain attack study. Stroke. 2006;37(3):769-75. DOI:10.1161/01.STR.0000204041.13466.4c</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Sammut-Powell C, Ashton C, Paroutoglou K, Parry-Jones A. Differences in Characteristics and Ambulance Pathway Adherence Between Strokes and Mimics Presenting to a Large UK Centralized Hyper Acute Stroke Unit (HASU). Front Neurol. 2021;12:646015. DOI:10.3389/fneur.2021.646015</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Rapillo CM, Dunet V, Salerno A, et al. Moving From CT-First to MRI-First Paradigm in Acute Ischemic Stroke: Treatment Rates, Time Metrics, Safety, and Outcomes. J Stroke. 2025;27(3):390-401. DOI:10.5853/jos.2025.02229</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Hidayat R, Fisher M, Rima SPP, et al. The Necessity of Using MRI as an Imaging Modality in Acute Code Stroke in Indonesia. Vasc Health Risk Manag. 2025;21:207-15. DOI:10.2147/VHRM.S503362</mixed-citation></ref></ref-list></back></article>
